慢性阻塞性肺病 (COPD) 的分子蓝图:诊断和治疗的新范式
Ilma Shakeel1,2, Anam Ashraf2, Mohammad Afzal1
1Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India.
慢性阻塞性肺病 (COPD) 是一个日益增长的全球健康威胁,导致大量死亡. 这篇综述探讨了COPD.
科学领域:
- 肺部医学 肺部医学
- 炎症研究 炎症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 的患病率和死亡率在全球范围内不断上升,使其成为第三大死亡原因.
- 慢性肺炎患者面临COVID-19的易感性和严重性增加,目前的治疗导致免疫抑制等不良影响.
- 了解COPD的细胞和炎症反应对于开发有效疗法至关重要.
研究的目的:
- 提供慢性阻塞性肺病 (COPD) 的批判性审查,包括其原因,诊断和治疗策略.
- 突出COPD诊断和治疗的新兴分子标和生物标志物.
- 讨论COPD管理对相关心血管疾病和COVID-19的影响.
主要方法:
- 对现有的COPD文献进行叙述性审查和批判性分析.
- 检查参与COPD病变的细胞和炎症途径.
- 摘要:最近生物标志物发现和COPD药物开发方面的进展.
主要成果:
- 确定吸烟是主要的风险因素,除了职业暴露,污染物,遗传和性别之外.
- 阐明了与COPD相关的关键炎症信号通路.
- 突出了信号传递物质作为新药候选物的潜力.
结论:
- 对COPD机制的深入理解对于开发有效的治疗药物和诊断生物标志物至关重要.
- 新的药物标和生物标志物正在出现,为改善疾病管理提供了希望.
- 有效的COPD管理策略可能会对相关心血管疾病和COVID-19结果产生积极影响.
更多相关视频
02:09Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
10:37Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
